share_log

Kura Sushi Posts Weak Q3 Results, Joins LegalZoom.com And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Kura Sushi Posts Weak Q3 Results, Joins LegalZoom.com And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

库拉寿司发布Q3业绩疲弱，与LegalZoom.com和其他大型股票一起在周三盘前下跌。
Benzinga ·  07/10 08:01

U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 50 points on Wednesday.

美股期货今早高开，纳斯达克期货周三上涨约50点。

Shares of Kura Sushi USA, Inc. (NASDAQ:KRUS) fell sharply in today's pre-market trading after the company posted downbeat results for its third quarter on Tuesday.

Kura Sushi USA股票（NASDAQ：KRUS）周二公布了第三季度业绩不佳的消息，今天的美国股市盘前交易中，该股票急剧下跌。

Kura Sushi reported quarterly earnings of $0.00 per share which missed the analyst consensus estimate of $0.01. The company reported quarterly sales of $63.082 million which missed the analyst consensus estimate of $63.101 million, according to data from Benzinga Pro.

苦艾酒（Kura Sushi）报告第三季度收益每股0.00美元，低于分析师平均预期的0.01美元。根据Benzinga Pro的数据，公司第三季度销售额为6308.2万美元，低于分析师平均预期的6310.1万美元。

Indivior shares fell 4.2% to $56.00 in the pre-market trading session.

Indivior股票在美股盘前交易中下跌4.2％，跌至56.00美元。

Here are some big stocks recording losses in today's pre-market trading session.

以下是在今天美股盘前交易中录得下跌的一些大型股票。

  • LegalZoom.com, Inc. (NASDAQ:LZ) shares dipped 18.3% to $6.41 in pre-market trading after the company announced a CEO transition and lowered its full year guidance.
  • Stardust Power Inc. (NASDAQ:SDST) declined 13.5% to $8.99 in pre-market trading after gaining around 9% on Tuesday.
  • 10x Genomics, Inc. (NASDAQ:TXG) shares fell 9.8% to $16.46 in pre-market trading. On Tuesday, Goldman Sachs analyst Matthew Sykes maintained 10x Genomics with a Sell and lowered the price target from $26 to $16.
  • IDEAYA Biosciences, Inc. (NASDAQ:IDYA) fell 6.4% to $36.13 in pre-market trading. IDEAYA priced $263 million public offering of 228,572 common shares and pre-funded warrants at $35 per share.
  • Hudson Pacific Properties, Inc. (NYSE:HPP) shares declined 4.9% to $4.90 in pre-market trading.
  • uniQure N.V. (NASDAQ:QURE) slipped 4.5% to $6.37 in pre-market trading. UniQure shares jumped 76% on Tuesday after the company announced updated interim data including up to 24 months of follow-up data from 29 treated patients enrolled in the ongoing U.S. and European Phase I/II clinical trials of AMT-130 for the treatment of Huntington's disease.
  • Lufax Holding Ltd (NYSE:LU) shares fell 3.7% to $2.86 in pre-market trading after gaining 17% on Tuesday.
  • LegalZoom.com，Inc.（NASDAQ：LZ）股票在CEO变更和业绩下调后的盘前交易中下跌18.3％，跌至6.41美元。
  • Stardust Power股票（NASDAQ：SDST）在周二上涨约9％后，在盘前交易中下跌13.5％，跌至8.99美元。
  • 10x genomics（NASDAQ：TXG）股票在盘前交易中下跌9.8％，跌至16.46美元。周二，高盛分析师Matthew Sykes维持10x Genomics卖出评级，并将目标价从26美元下调至16美元。
  • IDEAYA Biosciences股票（NASDAQ：IDYA）在盘前交易中下跌6.4％，跌至36.13美元。IDEAYA定价2.63亿美元向公众发行228,572股普通股及预付权证，价格为每股35美元。
  • Hudson Pacific Properties股票（NYSE：HPP）在盘前交易中下跌4.9％，跌至4.90美元。
  • uniQure N.V.股票（NASDAQ：QURE）在盘前交易中下跌4.5％，跌至6.37美元。周二，uniQure股票上涨76％，因公司宣布包括29名接受AMt-130用于治疗亨廷顿病的美国和欧洲I/II期临床试验的追踪数据，包括长达24个月的追踪数据。
  • Lufax Holding Ltd（纽交所：LU）股票在周二上涨17％后，在盘前交易中下跌3.7％，跌至2.86美元。

Now Read This:

现在阅读此内容：

  • Delta Air Lines Likely To Report Lower Q2 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
  • 达美航空预计将发布Q2季度收益下降的报告；以下是华尔街最准确分析师的最新预测变化。
声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发